Form4insider filings, from the source

SEC Form 4 · accession 0000899243-18-030866

Moderna, Inc. · MRNA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Paul Sagan
Director
Period of report
Dec 11, 2018
Accepted (ET)
Dec 13, 2018 · 4:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001682852

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Dec 11, 2018C367,776—A367,776IBy: The Paul Sagan Revocable Trust
Common StockF2holding———17,201IBy: Erwin Park LLC
Common StockF2holding———76,452IBy: The Chatham Trust

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series B Preferred StockF1,F2—Dec 11, 2018C367,776D——Common Stock367,7760I

Explanation of responses